Literature DB >> 17161309

Methodologies for developmental immunotoxicity (DIT) testing.

Rodney R Dietert1, Michael P Holsapple.   

Abstract

Developmental immunotoxicity has gained increasing recognition as a significant factor influencing the risk of later life disease. Based on the data collected thus far on different chemicals and drugs, the developing immune system can be significantly more sensitive than the adult immune system to xenobiotic-induced insult. There are distinct differences between the immune system surrounding birth and that in the mature adult as well as differences in the nature of immunotoxic changes based on age. Immunosuppresssion is not the only concern. Immunotoxic changes that increase the risk for allergic or autoimmune responses should also be considered. Therefore, one should not assume that immunotoxicity assays validated for adult exposure assessment are inherently the most predictive for developmental immunotoxicology (DIT) evaluation. Many of those adult-based protocols were developed solely to detect immunosuppression, whereas DIT concerns include shifts in immune balance. For this reason, it is useful to examine the various immune endpoints that have been employed in recent perinatal immunotoxicity studies, compare those against routine adult immunotoxicity evaluation protocols, and consider the options that are available for effective DIT testing. The results published on several chemicals and drugs in recent years suggest that functional tests are a front-line priority for perinatal immunotoxicity detection and that a combination of at least two functional tests (such as a multi-isotype T-dependent antibody response (TDARs), and a cell-mediated immune response assay such as the delayed-type hypersensitivity assay and/or T cell or NK cytotoxicity assays) should be paired with immune cell populations and histopathological analysis. Cytokine production measurements offer outstanding promise and may eventually be able to be substituted for other more laborious procedures. However, multi-cytokine analysis needs to be standardized in terms of optimum source for analysis and protocol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17161309     DOI: 10.1016/j.ymeth.2006.06.018

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  6 in total

1.  A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age.

Authors:  Todd A Jusko; Anneclaire J De Roos; Stephen M Schwartz; B Paige Lawrence; Lubica Palkovicova; Tomas Nemessanyi; Beata Drobna; Anna Fabisikova; Anton Kocan; Dean Sonneborn; Eva Jahnova; Terrance J Kavanagh; Tomas Trnovec; Irva Hertz-Picciotto
Journal:  Environ Res       Date:  2010-04-07       Impact factor: 6.498

2.  Maternal and early postnatal polychlorinated biphenyl exposure in relation to total serum immunoglobulin concentrations in 6-month-old infants.

Authors:  Todd A Jusko; Anneclaire J De Roos; Stephen M Schwartz; B Paige Lawrence; Lubica Palkovicova; Tomas Nemessanyi; Beata Drobna; Anna Fabisikova; Anton Kocan; Eva Jahnova; Terrance J Kavanagh; Tomas Trnovec; Irva Hertz-Picciotto
Journal:  J Immunotoxicol       Date:  2011 Jan-Mar       Impact factor: 3.000

3.  Developmental immunotoxicity testing and protection of children's health.

Authors:  Rodney R Dietert
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

4.  Effect of Carbon Black Nanoparticle on Neonatal Lymphoid Tissues Depending on the Gestational Period of Exposure in Mice.

Authors:  Atsuto Onoda; Saki Okamoto; Ryuhei Shimizu; Yasser S El-Sayed; Shiho Watanabe; Shuhei Ogawa; Ryo Abe; Masao Kamimura; Kohei Soga; Ken Tachibana; Ken Takeda; Masakazu Umezawa
Journal:  Front Toxicol       Date:  2021-08-11

Review 5.  Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies.

Authors:  Rodney R Dietert
Journal:  Adv Med       Date:  2014-01-23

6.  Blood Lead Concentrations and Antibody Levels to Measles, Mumps, and Rubella among U.S. Children.

Authors:  Todd A Jusko; Kyra Singh; Elizabeth A Greener; Marina Oktapodas Feiler; Kelly Thevenet-Morrison; B Paige Lawrence; Robert O Wright; Sally W Thurston
Journal:  Int J Environ Res Public Health       Date:  2019-08-22       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.